
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1B | -- | -- | $2.71 | -- |
07/30/2025 | Q2 | $1.1B | -- | -- | $2.57 | -- |
04/30/2025 | Q1 | $975.8M | $979.3M | $1.27 | $1.99 | -$0.72 |
02/05/2025 | Q4 | $999.2M | $995.2M | $1.39 | $2.45 | -$1.06 |
10/23/2024 | Q3 | $990.5M | $977.9M | $1.55 | $2.31 | -$0.76 |
07/24/2024 | Q2 | $1B | $1B | $1.28 | $2.30 | -$1.02 |
04/24/2024 | Q1 | $973.8M | $997.4M | $1.39 | $1.98 | -$0.59 |
01/31/2024 | Q4 | $933.7M | $956.7M | $1.64 | $2.18 | -$0.54 |
10/25/2023 | Q3 | -- | -- | $1.58 | $2.26 | -$0.68 |
07/26/2023 | Q2 | -- | -- | $1.46 | $2.04 | -$0.58 |
04/26/2023 | Q1 | -- | -- | $1.14 | $1.69 | -$0.55 |
02/01/2023 | Q4 | -- | -- | $0.54 | $1.53 | -$0.99 |
10/26/2022 | Q3 | -- | -- | $0.93 | $2.17 | -$1.24 |
07/27/2022 | Q2 | -- | -- | $1.44 | $2.23 | -$0.79 |
04/27/2022 | Q1 | -- | -- | $1.70 | $2.23 | -$0.53 |
02/02/2022 | Q4 | -- | -- | $2.40 | $2.73 | -$0.33 |
10/27/2021 | Q3 | -- | -- | $2.28 | $2.59 | -$0.31 |
07/28/2021 | Q2 | -- | -- | $2.51 | $2.53 | -$0.02 |
04/28/2021 | Q1 | -- | -- | $2.51 | $2.01 | $0.50 |
02/03/2021 | Q4 | -- | -- | $2.00 | $2.14 | -$0.14 |
10/21/2020 | Q3 | -- | -- | $1.76 | $0.73 | $1.03 |
07/22/2020 | Q2 | -- | -- | -$0.52 | -$0.05 | -$0.47 |
04/29/2020 | Q1 | -- | -- | $19.21 | $0.88 | $18.33 |
01/29/2020 | Q4 | -- | -- | $3.06 | $1.40 | $1.66 |
10/23/2019 | Q3 | -- | -- | $1.28 | $1.14 | $0.14 |
07/24/2019 | Q2 | -- | -- | $1.33 | $1.39 | -$0.06 |
04/24/2019 | Q1 | -- | -- | $1.17 | $0.83 | $0.34 |
01/29/2019 | Q4 | -- | -- | $1.20 | $1.15 | $0.05 |
10/24/2018 | Q3 | -- | -- | $1.24 | $1.19 | $0.05 |
07/25/2018 | Q2 | -- | -- | $1.30 | $1.09 | $0.21 |
04/25/2018 | Q1 | -- | -- | $1.17 | $0.97 | $0.20 |
01/30/2018 | Q4 | -- | -- | $1.19 | $0.96 | $0.23 |
10/26/2017 | Q3 | -- | -- | $1.01 | $0.81 | $0.20 |
07/27/2017 | Q2 | -- | -- | $0.85 | $0.73 | $0.12 |
04/27/2017 | Q1 | -- | -- | $0.85 | $0.67 | $0.18 |
01/31/2017 | Q4 | -- | -- | $0.67 | $0.67 | -- |
11/07/2016 | Q3 | -- | -- | $0.63 | $0.51 | $0.12 |
07/28/2016 | Q2 | -- | -- | $0.62 | $0.48 | $0.14 |
04/28/2016 | Q1 | -- | -- | $0.50 | $0.39 | $0.11 |
01/28/2016 | Q4 | -- | -- | $0.60 | $0.54 | $0.06 |
10/22/2015 | Q3 | -- | -- | $0.34 | $0.34 | -- |
Align Technology reported $979.3M worth of top line sales in its most recent quarter.
Align Technology announced earnings per share of $1.27 which represents a miss of analyst forecast a $1.99 per share.
Align Technology reported $680.1M that represents $9.24 per share over the last quarter.
Align Technology's earnings are forecast to grow from $5.62 per share to $9.33 per share next year representing an increase of 83.12%.
Align Technology's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.